BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 25189415)

  • 21. Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas.
    Gonzalez-Aguilar A; Idbaih A; Boisselier B; Habbita N; Rossetto M; Laurenge A; Bruno A; Jouvet A; Polivka M; Adam C; Figarella-Branger D; Miquel C; Vital A; Ghesquières H; Gressin R; Delwail V; Taillandier L; Chinot O; Soubeyran P; Gyan E; Choquet S; Houillier C; Soussain C; Tanguy ML; Marie Y; Mokhtari K; Hoang-Xuan K
    Clin Cancer Res; 2012 Oct; 18(19):5203-11. PubMed ID: 22837180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma.
    Montesinos-Rongen M; Schmitz R; Brunn A; Gesk S; Richter J; Hong K; Wiestler OD; Siebert R; Küppers R; Deckert M
    Acta Neuropathol; 2010 Oct; 120(4):529-35. PubMed ID: 20544211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
    Fischer L; Hummel M; Korfel A; Lenze D; Joehrens K; Thiel E
    Neuro Oncol; 2011 Oct; 13(10):1090-8. PubMed ID: 21803762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity.
    Thompsett AR; Ellison DW; Stevenson FK; Zhu D
    Blood; 1999 Sep; 94(5):1738-46. PubMed ID: 10477699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma.
    Gaidano G; Pasqualucci L; Capello D; Berra E; Deambrogi C; Rossi D; Maria Larocca L; Gloghini A; Carbone A; Dalla-Favera R
    Blood; 2003 Sep; 102(5):1833-41. PubMed ID: 12714522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin repertoire of primary lymphomas of the central nervous system.
    Montesinos-Rongen M; Purschke F; Küppers R; Deckert M
    J Neuropathol Exp Neurol; 2014 Dec; 73(12):1116-25. PubMed ID: 25383641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent Gene Mutations and Their Possible Roles in the Pathogenesis, Treatment and Prognosis of Primary Central Nervous System Lymphoma.
    Jin Q; Jiang H; Han Y; Li C; Zhang L; Zhang Y; Chai Y; Zeng P; Yue L; Wu C
    World Neurosurg; 2023 Feb; 170():99-106. PubMed ID: 36396049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
    Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
    Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatically mutated immunoglobulin IGHV@ genes without intraclonal heterogeneity indicate a postgerminal centre origin of primary intraocular diffuse large B-cell lymphomas.
    Malumbres R; Davis J; Ruiz P; Lossos IS
    Br J Haematol; 2007 Sep; 138(6):749-55. PubMed ID: 17760806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.
    Munch-Petersen HD; Asmar F; Dimopoulos K; Areškevičiūtė A; Brown P; Girkov MS; Pedersen A; Sjö LD; Heegaard S; Broholm H; Kristensen LS; Ralfkiaer E; Grønbæk K
    Acta Neuropathol Commun; 2016 Apr; 4():40. PubMed ID: 27101868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary central nervous system lymphoma in Korea: comparison of B- and T-cell lymphomas.
    Choi JS; Nam DH; Ko YH; Seo JW; Choi YL; Suh YL; Ree HJ
    Am J Surg Pathol; 2003 Jul; 27(7):919-28. PubMed ID: 12826884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal Evolution in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.
    Garcia-Reyero J; Martinez Magunacelaya N; Gonzalez Pereña A; Marcos Gonzalez S; Teran-Villagra N; Azueta A; Batlle A; Gonzalez de Villambrosia S; Revert Arce J; Montes-Moreno S
    Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):e68-e71. PubMed ID: 29629945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral Biopsy.
    Montesinos-Rongen M; Brunn A; Tuchscherer A; Borchmann P; Schorb E; Kasenda B; Altmüller J; Illerhaus G; Ruge MI; Maarouf M; Büttner R; Hansmann ML; Hallek M; Prinz M; Siebert R; Deckert M
    J Mol Diagn; 2020 Oct; 22(10):1300-1307. PubMed ID: 32745612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation.
    Deutsch AJ; Aigelsreiter A; Staber PB; Beham A; Linkesch W; Guelly C; Brezinschek RI; Fruhwirth M; Emberger W; Buettner M; Beham-Schmid C; Neumeister P
    Blood; 2007 Apr; 109(8):3500-4. PubMed ID: 17197434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The process of somatic hypermutation increases polyreactivity for central nervous system antigens in primary central nervous system lymphoma.
    Montesinos-Rongen M; Terrao M; May C; Marcus K; Blümcke I; Hellmich M; Küppers R; Brunn A; Deckert M
    Haematologica; 2021 Mar; 106(3):708-717. PubMed ID: 32193251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma.
    Coupland SE; Loddenkemper C; Smith JR; Braziel RM; Charlotte F; Anagnostopoulos I; Stein H
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3957-64. PubMed ID: 16249468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.
    Fontanilles M; Marguet F; Bohers É; Viailly PJ; Dubois S; Bertrand P; Camus V; Mareschal S; Ruminy P; Maingonnat C; Lepretre S; Veresezan EL; Derrey S; Tilly H; Picquenot JM; Laquerrière A; Jardin F
    Oncotarget; 2017 Jul; 8(29):48157-48168. PubMed ID: 28636991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular and clinical diversity in primary central nervous system lymphoma.
    Hernández-Verdin I; Kirasic E; Wienand K; Mokhtari K; Eimer S; Loiseau H; Rousseau A; Paillassa J; Ahle G; Lerintiu F; Uro-Coste E; Oberic L; Figarella-Branger D; Chinot O; Gauchotte G; Taillandier L; Marolleau JP; Polivka M; Adam C; Ursu R; Schmitt A; Barillot N; Nichelli L; Lozano-Sánchez F; Ibañez-Juliá MJ; Peyre M; Mathon B; Abada Y; Charlotte F; Davi F; Stewart C; de Reyniès A; Choquet S; Soussain C; Houillier C; Chapuy B; Hoang-Xuan K; Alentorn A
    Ann Oncol; 2023 Feb; 34(2):186-199. PubMed ID: 36402300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma.
    Leithäuser F; Bäuerle M; Huynh MQ; Möller P
    Blood; 2001 Nov; 98(9):2762-70. PubMed ID: 11675349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
    Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
    Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.